A METHOD FOR FRICTIONLESS SIGNATURE-BASED HIGH-RISK PERMISSIONS MANAGEMENT ON COMPUTING DEVICES AND SYSTEM THEREOF

The present disclosure provides a method for frictionless signature-based high-risk permissions management on computing devices. The method includes an onboarding process involving the inclusion of new software vendors by the OS or MDM vendor, a process that verifies vendor legitimacy and the necessity of their access to sensitive resources. During onboarding, the OS or MDM vendor generates an upload key, securely provided to the software vendor, and an app signing key, securely retained within the vendor\u27s Key Management System (KMS). Further, the method includes releasing or publishing applications to a digital distribution service managed by the OS or MDM vendor involves software vendors declaring necessary permissions and signing applications with the upload key before uploading them to distribution services. The OS or MDM vendor validates the application, ensuring vendor correspondence, adherence to platform-specific signature rules, and pre-clearance for resource access. Upon successful verification, the application is signed with permission-specific certificates and the app signing key, preparing it for distribution. Furthermore, the method includes downloading and installation of applications on end-point computing devices encompass the OS verification process. If successful, the application is installed with normal or low-risk permissions without user consent. Moreover, for each requested sensitive resource and feature access, the application is verified with the corresponding permission key, granting dangerous or high-risk permissions seamlessly

Complications following an unnecessary peri-operative plasma transfusion and literature review

Plasma is used to correct coagulopathies, but not all coagulation abnormalities are clinically significant enough to require correction before an invasive procedure. We report an 82-year-old female who, in response to a mildly prolonged INR of unknown etiology, was unnecessarily transfused with plasma in advance of elective surgery. The patient suffered a moderately severe transfusion reaction, including hives and voice hoarseness, which caused a 4-week delay in her surgery. This delay and adverse reaction could have been avoided had the principles of evidence based plasma therapy, which we herein review, been followed and if the etiology of the mildly elevated INR been investigated before the day of her surgery